D-Serine Treatment of Negative Symptoms and Cognitive Deficits in Schizophrenia

Mise à jour : Il y a 4 ans
Référence : NCT00237809

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

This study is based on the hypothesis that by increasing N-methyl-D-aspartic acid (NMDA) receptor function in the brain and thereby increasing the capacity of the brain to both form new connections and strengthen existing connections, schizophrenic patients may derive both greater and sustained benefit from cognitive retraining.


Critère d'inclusion

  • Schizophrenia,Schizoaffective Disorder

Liens